Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

New Joint Space Mapping Technique Doubles Diagnostic Sensitivity for Osteoarthritis

Renée Bacher  |  Issue: November 2018  |  November 18, 2018

JSM performance at the extremes of disease. Joint space margins are shown in green as seen in axial, coronal and sagittal planes (left to right) at two left hips. (a) An individual with a radiographic K&L grade of 0 (no disease) and minimum joint space width of 2.0 mm. (b) An individual with a radiographic K&L grade of 3 (moderate disease) and minimum joint space width of 0 mm. This demonstrates that JSM is still able to represent joint space width as it approaches zero, important for analysis in advanced disease. Credit: Reprinted by permission from “A new quantitative 3D approach to imaging of structural joint disease,” Scientific Reports, under the Creative Commons Attribution 4.0 International (CC BY) license (https://creativecommons.org/licenses/by/4.0/legalcode).

JSM performance at the extremes of disease. Joint space margins are shown in green as seen in axial, coronal and sagittal planes (left to right) at two left hips. (a) An individual with a radiographic K&L grade of 0 (no disease) and minimum joint space width of 2.0 mm. (b) An individual with a radiographic K&L grade of 3 (moderate disease) and minimum joint space width of 0 mm. This demonstrates that JSM is still able to represent joint space width as it approaches zero, important for analysis in advanced disease.
Credit: Reprinted by permission from “A new quantitative 3D approach to imaging of structural joint disease,” Scientific Reports, under the Creative Commons Attribution 4.0 International (CC BY) license (https://creativecommons.org/licenses/by/4.0/legalcode).

CT or MRI?

The researchers focused on CT scans rather than MRIs because the 3D information is richer, with better spatial resolution in all three planes. “We have been able to adapt the technique to work with MRI, but this has mainly focused on 3D mapping of cartilage thickness at the knee, which MRI is far better at visualizing,” Dr. Turmezei says. “It is still important to consider [CT] joint space mapping as complementary to other imaging techniques such as MRI, which has its own strengths over CT, such as the ability to depict soft tissues such as cartilage and ligaments as well as inflammation.” CT does better show mineralized structures, such as bone.

As MRI techniques develop, however, a similar 3D joint space mapping approach will likely become possible with clinical MRI data. Dr. Turmezei’s PhD thesis in 2017 showed it was feasible, but the sequences needed to do it are not in everyday clinical use. “One of the great strengths of CT joint space mapping is that it uses regular CT imaging data that can be acquired on any hospital scanner right now,” he says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Prior to joining together, two of the researchers had already been collaborating for a few years, using cortical bone mapping to investigate thickness changes in the diagnosis and treatment of osteoporosis. With his background in radiology, Dr. Turmezei was able to bring a new set of clinical problems around osteoarthritis imaging for the team to solve.

Because his PhD was in the engineering department, Dr. Turmezei says he had to learn advanced math and coding to develop and validate the algorithm, and that experience brought him skills he continues to use in his research and clinical practice.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“I feel very lucky to have worked with and between these research groups that continue to be committed to solving clinical problems with novel engineering solutions,” he says. “The keystone to the success of these collaborations is the ability to identify meaningful clinical problems that need a solution. Otherwise time is wasted on developing tools that don’t have any relevant clinical utility.”  

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:OsteoarthritisTesting

Related Articles

    Envision Arthritis Pathology

    April 1, 2008

    MRI advances in RA and OA

    Imaging in Ankylosing Spondylitis

    April 1, 2015

    MRI inflammation, fat and new bone formation in the sacroiliac joints, spine in patients with AS

    Osteoarthritis Quo Vadis

    March 1, 2008

    Our knowledge of OA has progressed far—does a cure lie ahead?

    Imaging of Axial Psoriatic Arthritis

    May 9, 2022

    The axial phenotype of psoriatic arthritis (axPsA) is an excellent example of a major controversy in rheumatology that has become the focus of attention because of the emergence of new therapies with different mechanisms of action for alleviating joint inflammation. It was first described in 1961 but, until recently, it has largely remained under the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences